Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from females
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djaf138 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Yijian Fan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States. Hauptthemen laut MEDLINE: Killer Cells, Natural, Lung Neoplasms, Adenocarcinoma of Lung, Protein Serine-Threonine Kinases. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Winship Invest$Team Science, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background
This study addressed the enigma of sex differences in smoking-related lung cancer, particularly focusing on the low LKB1 mutation frequency in female patients with lung adenocarcinoma.
Methods
Sex bias was studied with a genetically engineered mouse model and various tail-vein injection models. Immune cells were analyzed by antibody-depletion study, flow cytometry, and immunofluorescence. The relevance of our findings to human disease was validated by evaluating various lung adenocarcinoma datasets. All statistical tests are 2-sided.
Results
A statistically significant percentage of females are resistant to LKB1-mutant tumor formation in our models, reflecting this sex difference in humans. Natural killer (NK) cells were identified as a critical factor in this sex-biased response. This sex difference was observed primarily in LKB1-mutant lung adenocarcinoma, probably due to their low major histocompatibility complex class I level, making them the ideal target for NK cells through the missing-self recognition. Although females resistant to LKB1-mutant lung adenocarcinoma formation did not have enhancement of any specific NK subpopulation, our immunofluorescence analysis revealed high numbers of NKs in female lungs even with the presence of LKB1-mutant lung adenocarcinoma. Our gene set enrichment analysis of The Cancer Genome Atlas–lung adenocarcinoma dataset also showed that female LKB1-mutant lung adenocarcinoma patients have a stronger NK-mediated response after adjusting for other male-female differences using the LKB1 wild–type lung adenocarcinoma dataset.
Conclusion
Females have a stronger NK-mediated response against LKB1-mutant lung adenocarcinoma, which was present in our mouse model and the human lung adenocarcinoma dataset. This study revealed a novel role of NK cells in suppressing LKB1-mutant lung adenocarcinoma in females, which should be assessed in the clinical setting in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, United States.
- Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
- Cancer Animal Models Shared Resource of Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, United States.
- Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, GA, United States.
- Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, United States.
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States.
ORCID-Profile: Rui Jin, Lenore Monterroza, Angelo Marra, Xiulei Mo, Haian Fu, Melissa Gilbert-Ross, Adam I Marcus, Rabindra Tirouvanziam, Yuan Liu, Wei Zhou
Förderung
- Winship Invest$Team Science
- NIA NIH HHS
- NCI NIH HHS
- NCI Lung Cancer Spore
- Career Enhancement Core
- NIH
- Career Enhancement Program
- Winship shared resources
Zitieren
APA
Fan, Y., Jin, R., Monterroza, L., Liu, X., Huang, C., Marra, A., Mo, X., Fu, H., Gilbert-Ross, M., Marcus, A. I., Tirouvanziam, R., Liu, Y., Schneider, F., & Zhou, W. (2025). Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from females. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf138
Vancouver
Fan Y, Jin R, Monterroza L, Liu X, Huang C, Marra A, et al. Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from females. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf138
BibTeX
@article{Fan2025,
author = {Fan, Yijian and Jin, Rui and Monterroza, Lenore and Liu, Xiuju and Huang, Chunzi and Marra, Angelo and Mo, Xiulei and Fu, Haian and Gilbert-Ross, Melissa and Marcus, Adam I and Tirouvanziam, Rabindra and Liu, Yuan and Schneider, Frank and Zhou, Wei},
title = {Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from females},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djaf138}
}
EUVIMED